East Coast product manager for the US commercialization of PuraSinus™. PuraSinus™ is a novel self-assembling peptide that creates a hydrogel solution providing unrivaled value and results. PuraSinus™ is a space occupying gel stent intended to separate and prevent adhesions between mucosal surfaces, help to control minimal bleeding and act as an adjunct to aid in the natural healing process. PuraSinus™ is indicated following nasal/sinus surgery or trauma to prevent lateralization of the middle turbinate and formation of nasal adhesions during the post-operative period.

Regional Business Manager for North America start-up, 3-D Matrix. Responsibilities include product management, sales management and market development of self-assembling peptide RADA16 for the East Coast. Current indications for RADA16 in the US include ENT, Dermatology, GI and Oral.